Title: Increased prevalence of <i>Helicobacter pylori</i> infection in females treated with dopaminergic drugs for hyperprolactinaemia
Abstract: Clinical EndocrinologyVolume 48, Issue 3 p. 373-374 Increased prevalence of Helicobacter pylori infection in females treated with dopaminergic drugs for hyperprolactinaemia Massimo Giusti, Massimo Giusti Department of Endocrinology, University of Genoa, Genoa, Italy,Search for more papers by this authorMaria Rosaria Falivene, Maria Rosaria Falivene Department of Endocrinology, University of Genoa, Genoa, Italy,Search for more papers by this authorLuca Foppiani, Luca Foppiani Department of Endocrinology, University of Genoa, Genoa, Italy,Search for more papers by this authorVincenzo Savarino, Vincenzo Savarino Department of Gastroenterology, University of Genoa, Genoa, Italy,Search for more papers by this authorAlessandro Costa, Alessandro Costa Institute of Microbiology, University of Genoa, Genoa, ItalySearch for more papers by this author Massimo Giusti, Massimo Giusti Department of Endocrinology, University of Genoa, Genoa, Italy,Search for more papers by this authorMaria Rosaria Falivene, Maria Rosaria Falivene Department of Endocrinology, University of Genoa, Genoa, Italy,Search for more papers by this authorLuca Foppiani, Luca Foppiani Department of Endocrinology, University of Genoa, Genoa, Italy,Search for more papers by this authorVincenzo Savarino, Vincenzo Savarino Department of Gastroenterology, University of Genoa, Genoa, Italy,Search for more papers by this authorAlessandro Costa, Alessandro Costa Institute of Microbiology, University of Genoa, Genoa, ItalySearch for more papers by this author First published: 25 December 2001 https://doi.org/10.1046/j.1365-2265.1998.00471.xCitations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Jones, S.L., Patchett, S., Anderson, J.V., Farthing, M.J.G., Besser, G.M., Wass, J.A.H. (1995) Prevalence of Helicobacter pylori in acromegalic patients during treatment with octreotide. Clinical Endocrinology, 43, 683 687. 2 Figura, N., Guarino, E., Gragnoli, A., Di Cairano, G., Lore', F., Cataldo, D. (1996) H. Pylori (HP) infection and thyroid disease. Gut, 39, (suppl): A 93. 3 Cammarota, G., Tursi, A., Papa, A., Cuoco, L., De Marinis, L, Valle, D., Fedeli, G., Gasbarrini, G. (1997) Helicobacter pylori, gastric mucosa-associated lymphoid tissue and autoimmune thyroid diseases . Gastroenterology International, 10, 43 45. 4 Ojetti, V., Gasbarrini, A., Pitocco, D., De Luca, A., Sanz Torre, E., Candelli, M., Franceschi, F., Di Campli, C., Pola, P., Gasbarrini, G., Ghirlanda, G. (1997) Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus . Gastroenterology International, 14, 46 47. 5 Reber, P.M. (1993). Prolactin and immunomodulation. The American Journal of Medicine, 95, 637 644. Citing Literature Volume48, Issue3March 1998Pages 373-374 ReferencesRelatedInformation